MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (AvastinĀ®) in Relapsed Metastatic Colorectal Cancer Patients
Stock Information for MEI Pharma Inc.
Loading
Please wait while we load your information from QuoteMedia.